At the cutting edge

At the
cutting edge.

Research for life

Research
for life.

Innovation and performance

Innovation and
performance.

Latest

Whats new.

November 22nd 2019
investor updates
November 1st 2019
press releases
November 1st 2019
press releases
November 1st 2019
press releases

Upcoming Events

Whats next.

Who we are

About us.

passion.

It takes a great deal of passion on the fight against cancer. We put our heart and soul into winning it.

know-how.

Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.

research.

Accurate research is the strong foundation for developing potential in effective treatment.

What is LAG3?
Lymphocyte-activation gene 3, or LAG-3 (LAG3), is a cell surface molecule with biologic effects on T cell function.
LAG3 is being used for many cancer immunotherapy treatments including Eftilagimod Alpha from Immutep.